LATS2 Antikörper
-
- Target Alle LATS2 Antikörper anzeigen
- LATS2 (LATS, Large Tumor Suppressor, Homolog 2 (Drosophila) (LATS2))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser LATS2 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Western Blotting (WB), Immunofluorescence (IF)
- Spezifität
- Reacts with human LATS2 protein
- Aufreinigung
- Purified (protein A)
- Immunogen
- LATS2 tagged partial recombinant protein
- Top Product
- Discover our top product LATS2 Primärantikörper
-
-
- Applikationshinweise
-
Working dilution: Optimal dilutions should be determined by the end user.
The following are guidelines only:
WB1:500 - 1:5000 IF1:200 - 1:1000 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Must be reconstituted in distilled water.
- Konzentration
- 1 mg/mL
- Buffer
- Tris 0,1M, glycine 0,1M, sucrose 2 %
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
- Haltbarkeit
- 24 months
-
- Target
- LATS2 (LATS, Large Tumor Suppressor, Homolog 2 (Drosophila) (LATS2))
- Andere Bezeichnung
- Serine/threonine-Protein Kinase LATS2 (LATS2 Produkte)
- Synonyme
- 4932411G09Rik antikoerper, AV277261 antikoerper, AW228608 antikoerper, KPM antikoerper, lats2 antikoerper, large tumor suppressor kinase 2 antikoerper, large tumor suppressor 2 antikoerper, LATS2 antikoerper, Lats2 antikoerper, lats2 antikoerper
- Hintergrund
- Negative regulator of YAP1 in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis.
- Gen-ID
- 26524
- UniProt
- Q9NRM7
-